Cargando…
Efficacy of Docosahexaenoic Acid for the Prevention of Necrotizing Enterocolitis in Preterm Infants: A Randomized Clinical Trial
Necrotizing enterocolitis (NEC) is an inflammatory bowel disease and a leading cause of morbidity and mortality in preterm infants. In this study, a randomized double-blind parallel-group (1:1) trial was carried out in two neonatal intensive care units of two tertiary hospitals. Two hundred and twen...
Autores principales: | Bernabe-García, Mariela, Calder, Philip C., Villegas-Silva, Raúl, Rodríguez-Cruz, Maricela, Chávez-Sánchez, Luis, Cruz-Reynoso, Leonardo, Mateos-Sánchez, Leovigildo, Lara-Flores, Gabriel, Aguilera-Joaquín, Augusto R., Sánchez-García, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922869/ https://www.ncbi.nlm.nih.gov/pubmed/33671220 http://dx.doi.org/10.3390/nu13020648 |
Ejemplares similares
-
Necrotizing Enterocolitis in Moderate Preterm Infants
por: Nair, Jayasree, et al.
Publicado: (2018) -
Incidence, Treatment, and Outcome Trends of Necrotizing Enterocolitis in Preterm Infants: A Multicenter Cohort Study
por: Zozaya, Carlos, et al.
Publicado: (2020) -
Impact of Docosahexaenoic acid supplementation on proinflammatory cytokines release and the development of Necrotizing enterocolitis in preterm Neonates: A randomized controlled study
por: Abou El Fadl, Dina Khaled, et al.
Publicado: (2021) -
Effects of Probiotics and Lactoferrin on Necrotizing Enterocolitis in Preterm Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2021) -
Necrotizing enterocolitis: controversies and challenges
por: Zani, Augusto, et al.
Publicado: (2015)